SCHEMBL720533

SCHEMBL720533

O=S(=O)(c1ccccc1CF)c1ccccc1CF

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.44
MMP2 P08253 7/20 0.41
MMP12 P39900 6/20 0.41
MMP13 P45452 6/20 0.41
MMP14 P50281 6/20 0.41
MMP1 P03956 5/20 0.41
MMP3 P08254 5/20 0.41
MMP9 P14780 5/20 0.41
MMP8 P22894 3/20 0.41
MMP16 P51512 3/20 0.41
CYP2D6 P10635 1/20 0.40
HSD11B1 P28845 1/20 0.40
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
ALB P02768 1/20 0.37
LMNA P02545 1/20 0.36
CTSB P07858 1/20 0.36
LOXL2 Q9Y4K0 2/20 0.36
PLCG1 P19174 1/20 0.35
HTR6 P50406 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5183551 0.82 ALDH1A1 (0.39) GAAMMP2MMP12MMP13MMP14
SCHEMBL31471001 0.82 CA2 (0.50) PLCG1
SCHEMBL3651546 0.82 CA2 (0.50) PLCG1
SCHEMBL777101 0.82 MYC (0.44) MMP2MMP12MMP13MMP14MMP1
Hydrochloric Acid SCHEMBL5794382 0.80 CA2 (0.48)
SCHEMBL780568 0.78 CTSB (0.55) GAAMMP2MMP12MMP13MMP14
SCHEMBL4434908 0.76 CYP2D6 (0.56) GAAMMP2MMP12MMP13MMP14
SCHEMBL6680426 0.76 GAA (0.50) GAAMMP2MMP12MMP13MMP14
SCHEMBL1148229 0.76 GAA (0.44) GAAMMP2MMP12MMP13MMP14
SCHEMBL3535459 0.76 GAA (0.44) GAAMMP2MMP12MMP13MMP14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 89 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119944075-A Deep eutectic electrolyte based on phenylmethylsulfone and fluorine substituted derivatives thereof, preparation method thereof and lithium battery 哈尔滨工业大学(深圳)(哈尔滨工业大学深圳科技创新研究院) 2025-05-06 CN claimed
CN-118763273-A Sulfonyl deep eutectic polymer electrolyte and preparation and application thereof 青岛赛锂达储能产业技术研究院有限公司 2024-10-11 CN claimed
CN-119944075-A Deep eutectic electrolyte based on phenylmethylsulfone and fluorine substituted derivatives thereof, preparation method thereof and lithium battery 哈尔滨工业大学(深圳)(哈尔滨工业大学深圳科技创新研究院) 2025-05-06 CN disclosed
CN-119230953-A Fluorinated electrolyte composition for chalcogen cells II-VI特拉华股份有限公司 2024-12-31 CN disclosed
CN-113302184-B 1,3, 4-Oxadiazolinone compounds and medicaments 日本新药株式会社 2024-11-22 CN disclosed
CN-118763273-A Sulfonyl deep eutectic polymer electrolyte and preparation and application thereof 青岛赛锂达储能产业技术研究院有限公司 2024-10-11 CN disclosed
US-12100809-B2 Non-aqueous liquid electrolyte and non-aqueous liquid electrolyte secondary battery MITSUBISHI CHEMICAL CORPORATION (JP) 2024-09-24 US disclosed
CN-118315668-A Wide temperature range high voltage sodium ion battery electrolyte and sodium ion battery 珠海钠壹新能源科技有限公司 2024-07-09 CN disclosed
CN-112174960-B Toll-like receptor modulating 4, 6-diamino-pyrido [3,2-D ] pyrimidine compounds 吉利德科学公司 2023-10-10 CN disclosed
US-20220149436-A1 NON-AQUEOUS LIQUID ELECTROLYTE AND NON-AQUEOUS LIQUID ELECTROLYTE SECONDARY BATTERY MITSUBISHI CHEMICAL CORPORATION (JP) 2022-05-12 US disclosed
US-11283107-B2 Non-aqueous liquid electrolyte and non-aqueous liquid electrolyte secondary battery MITSUBISHI CHEMICAL CORPORATION (JP) 2022-03-22 US disclosed
WO-1995007917-A1 5-(1-FLUORO-VINYL)-1H-PYRIMIDINE-2,4-DIONE DERIVATIVES USEFUL AS ANTINEOPLASTIC AGENTS MERRELL PHARMACEUTICALS INC. (US) 1995-03-23 WO disclosed
EP-0640092-A1 A PROCESS FOR THE PREPARATION OF RIBONUCLEOTIDE REDUCTASE INHIBITORS. MERRELL DOW PHARMA (US) 1995-03-01 EP disclosed
US-5378693-A Antitumor agents or viricides MERRELL DOW PHARMACEUTICALS INC. (US) 1995-01-03 US disclosed
EP-0365849-B1 Novel 2'-halomethylidene, 2'-ethenylidene and 2'-ethynyl adenosine derivatives MERRELL DOW PHARMA (US) 1994-09-14 EP disclosed
EP-0372268-B1 Novel 2'-halomethylidene, 2'-ethenylidene and 2'-ethynyl cytidine, uridine and guanosine derivatives MERRELL DOW PHARMA (US) 1994-05-04 EP disclosed
WO-1993023414-A1 A PROCESS FOR THE PREPARATION OF RIBONUCLEOTIDE REDUCTASE INHIBITORS MERRELL DOW PHARMACEUTICALS INC. (US) 1993-11-25 WO disclosed
WO-1993020825-A1 METHOD OF TREATING CANCER BY CONJUNCTIVE THERAPY WITH 2'-HALOMETHYLIDENE DERIVATIVES AND AN S-PHASE OR M-PHASE SPECIFIC ANTINEOPLASTIC AGENT MERRELL DOW PHARMACEUTICALS INC. (US) 1993-10-28 WO disclosed
EP-0372268-A1 Novel 2'-halomethylidene, 2'-ethenylidene and 2'-ethynyl cytidine, uridine and guanosine derivatives MERRELL DOW PHARMACEUTICALS INC. (US) 1990-06-13 EP disclosed
EP-0365849-A2 Novel 2'-halomethylidene, 2'-ethenylidene and 2'-ethynyl adenosine derivatives MERRELL DOW PHARMACEUTICALS INC. (US) 1990-05-02 EP disclosed